Logo

Revived Febit Biotech to Employ 50 by Year-End

Mar 20, 2006

NEW YORK, March 20 (GenomeWeb News) - Febit Biotech, the microarray manufacturer that got a second life last year, said today that it has gradually added employees and expects a headcount of 50 by the end of 2006.

 

The company said that sales of its Geniom DNA analysis instrument "were on budget already in the year of Febit's re-establishment."

 

As GenomeWeb News reported last May, Febit Biotech was created 19 months after Febit went out of business.

 

The company moved to a new facility in Heidelberg, Germany, and received an undisclosed investment from its original investors, Dietmar and Oliver Hopp.

Breaking News
The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.